In a remarkable achievement for India's healthcare technology sector, Agatsa Software Pvt Ltd has secured the prestigious Anjani Mashelkar Prize 2025 for its groundbreaking EasyTouch Plus device. This innovative technology promises to transform diabetes management by offering completely non-invasive blood sugar monitoring.
A Revolutionary Approach to Diabetes Monitoring
The award ceremony took place during the 13th National Conference on Social Innovation at the Pune International Centre. Siddharth Sharma, Chief Executive Officer of Tata Trusts, alongside Dr R A Mashelkar, Chairman of the Anjani Mashelkar Foundation, presented the honor to company founders Rahul and Neha Rastogi.
EasyTouch Plus represents a significant leap forward in glucose monitoring technology. Unlike traditional methods that require finger pricks and test strips, this pocket-sized device delivers indicative glucose trends in under 15 seconds. Users simply place their fingertip on the device, eliminating the pain, discomfort, and recurring costs associated with conventional monitoring systems.
Making Diabetes Care Accessible and Affordable
The financial benefits of EasyTouch Plus are as impressive as its technological innovation. For the average person living with diabetes, the device reduces the effective cost per test to just 25 paise. This represents approximately 1/100th the cost of traditional glucose monitoring methods, making long-term diabetes management both painless and economically sustainable for millions of Indians.
Since its market launch in June 2025, EasyTouch Plus has already seen tremendous adoption, with over 12,000 devices sold and actively being used across India. This rapid market acceptance underscores the urgent need for affordable, user-friendly healthcare solutions in the country.
Serial Innovators Continuing Their Legacy
This isn't the first time Rahul and Neha Rastogi have been recognized by the Anjani Mashelkar Foundation. The entrepreneurial duo previously won the Anjani Mashelkar Prize in 2015 for their handheld ECG innovation, SanketLife. That initial product evolved into a sophisticated 12-lead portable ECG device that has seen remarkable success, with over 25,000 units sold across 12 countries.
Dr R A Mashelkar emphasized the significance of their continued innovation, stating: "This technology represents what India needs in healthcare today – innovation that combines excellence, affordability, and ease of use. We are proud that innovators nurtured at the Anjani Mashelkar Foundation are not one-time but serial innovators, continuing to solve grand challenges. We look forward to supporting EasyTouch Plus as it scales for community healthcare."
The Anjani Mashelkar Foundation, established by Dr R A Mashelkar in memory of his late mother, has a distinguished history of recognizing groundbreaking medical innovations. Over the past 15 years, the foundation has honored more than 15 breakthrough innovations in medical diagnostics, cementing its role as a catalyst for healthcare transformation in India.
The success of EasyTouch Plus signals a new era in diabetes management, where technology not only improves medical outcomes but also addresses the critical issues of accessibility and affordability that have long challenged healthcare systems worldwide.
